Literature DB >> 29412496

Characterization of active and infiltrative tumorous subregions from normal tissue in brain gliomas using multiparametric MRI.

Anahita Fathi Kazerooni1,2, Mahnaz Nabil3, Mehdi Zeinali Zadeh4, Kavous Firouznia5, Farid Azmoudeh-Ardalan6, Alejandro F Frangi7, Christos Davatzikos8, Hamidreza Saligheh Rad1,2.   

Abstract

BACKGROUND: Targeted localized biopsies and treatments for diffuse gliomas rely on accurate identification of tissue subregions, for which current MRI techniques lack specificity.
PURPOSE: To explore the complementary and competitive roles of a variety of conventional and quantitative MRI methods for distinguishing subregions of brain gliomas. STUDY TYPE: Prospective. POPULATION: Fifty-one tissue specimens were collected using image-guided localized biopsy surgery from 10 patients with newly diagnosed gliomas. FIELD STRENGTH/SEQUENCE: Conventional and quantitative MR images consisting of pre- and postcontrast T1 w, T2 w, T2 -FLAIR, T2 -relaxometry, DWI, DTI, IVIM, and DSC-MRI were acquired preoperatively at 3T. ASSESSMENT: Biopsy specimens were histopathologically attributed to glioma tissue subregion categories of active tumor (AT), infiltrative edema (IE), and normal tissue (NT) subregions. For each tissue sample, a feature vector comprising 15 MRI-based parameters was derived from preoperative images and assessed by a machine learning algorithm to determine the best multiparametric feature combination for characterizing the tissue subregions. STATISTICAL TESTS: For discrimination of AT, IE, and NT subregions, a one-way analysis of variance (ANOVA) test and for pairwise tissue subregion differentiation, Tukey honest significant difference, and Games-Howell tests were applied (P < 0.05). Cross-validated feature selection and classification methods were implemented for identification of accurate multiparametric MRI parameter combination.
RESULTS: After exclusion of 17 tissue specimens, 34 samples (AT = 6, IE = 20, and NT = 8) were considered for analysis. Highest accuracies and statistically significant differences for discrimination of IE from NT and AT from NT were observed for diffusion-based parameters (AUCs >90%), and the perfusion-derived parameter as the most accurate feature in distinguishing IE from AT. A combination of "CBV, MD, T2 _ISO, FLAIR" parameters showed high diagnostic performance for identification of the three subregions (AUC ∼90%). DATA
CONCLUSION: Integration of a few quantitative along with conventional MRI parameters may provide a potential multiparametric imaging biomarker for predicting the histopathologically proven glioma tissue subregions. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2018;48:938-950.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  glioma; imaging biomarker; intratumor heterogeneity; machine learning; multiparametric MRI

Mesh:

Substances:

Year:  2018        PMID: 29412496      PMCID: PMC6081259          DOI: 10.1002/jmri.25963

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  37 in total

1.  Longitudinal diffusion tensor imaging in a rat brain glioma model.

Authors:  Silvia Lope-Piedrafita; Maria L Garcia-Martin; Jean-Philippe Galons; Robert J Gillies; Theodore P Trouard
Journal:  NMR Biomed       Date:  2008-10       Impact factor: 4.044

2.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 4.  Survival in glioblastoma: a review on the impact of treatment modalities.

Authors:  P D Delgado-López; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2016-03-10       Impact factor: 3.405

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

6.  Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.

Authors:  N Sadeghi; N D'Haene; C Decaestecker; M Levivier; T Metens; C Maris; D Wikler; D Baleriaux; I Salmon; S Goldman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

7.  Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.

Authors:  Gisele B Caseiras; Sophie Chheang; James Babb; Jeremy H Rees; Nicole Pecerrelli; Daniel J Tozer; Christopher Benton; David Zagzag; Glyn Johnson; Adam D Waldman; H R Jäger; Meng Law
Journal:  Eur J Radiol       Date:  2009-02-06       Impact factor: 3.528

8.  Multi-parametric (ADC/PWI/T2-w) image fusion approach for accurate semi-automatic segmentation of tumorous regions in glioblastoma multiforme.

Authors:  Anahita Fathi Kazerooni; Meysam Mohseni; Sahar Rezaei; Gholamreza Bakhshandehpour; Hamidreza Saligheh Rad
Journal:  MAGMA       Date:  2014-04-02       Impact factor: 2.310

9.  Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas.

Authors:  Stephen J Price; Alonso Peña; Neil G Burnet; Raj Jena; Hadrian A L Green; T Adrian Carpenter; John D Pickard; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2004-06-25       Impact factor: 5.315

10.  Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.

Authors:  Leland S Hu; Shuluo Ning; Jennifer M Eschbacher; Nathan Gaw; Amylou C Dueck; Kris A Smith; Peter Nakaji; Jonathan Plasencia; Sara Ranjbar; Stephen J Price; Nhan Tran; Joseph Loftus; Robert Jenkins; Brian P O'Neill; William Elmquist; Leslie C Baxter; Fei Gao; David Frakes; John P Karis; Christine Zwart; Kristin R Swanson; Jann Sarkaria; Teresa Wu; J Ross Mitchell; Jing Li
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more
  17 in total

1.  Characterization of hardware-related spatial distortions for IR-PETRA pulse sequence using a brain specific phantom.

Authors:  Sima Ahmadian; Iraj Jabbari; Seyed Mehdi Bagherimofidi; Hamidreza Saligheh Rad
Journal:  MAGMA       Date:  2020-07-06       Impact factor: 2.310

Review 2.  Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.

Authors:  Anahita Fathi Kazerooni; Spyridon Bakas; Hamidreza Saligheh Rad; Christos Davatzikos
Journal:  J Magn Reson Imaging       Date:  2019-08-27       Impact factor: 4.813

Review 3.  Precision Digital Oncology: Emerging Role of Radiomics-based Biomarkers and Artificial Intelligence for Advanced Imaging and Characterization of Brain Tumors.

Authors:  Reza Forghani
Journal:  Radiol Imaging Cancer       Date:  2020-07-31

Review 4.  Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas.

Authors:  Jayapalli Rajiv Bapuraj; Nicholas Wang; Ashok Srinivasan; Arvind Rao
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

5.  Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging.

Authors:  Lu Zhang; Hongyu Zhou; Dongsheng Gu; Jie Tian; Bin Zhang; Di Dong; Xiaokai Mo; Jing Liu; Xiaoning Luo; Shufang Pei; Yuhao Dong; Wenhui Huang; Qiuyin Chen; Changhong Liang; Zhouyang Lian; Shuixing Zhang
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

6.  Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Authors:  Niels Verburg; Thomas Koopman; Maqsood M Yaqub; Otto S Hoekstra; Adriaan A Lammertsma; Frederik Barkhof; Petra J W Pouwels; Jaap C Reijneveld; Jan J Heimans; Annemarie J M Rozemuller; Anne M E Bruynzeel; Frank Lagerwaard; William P Vandertop; Ronald Boellaard; Pieter Wesseling; Philip C de Witt Hamer
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

Review 7.  GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma.

Authors:  Patricia Clement; Thomas Booth; Fran Borovečki; Kyrre E Emblem; Patrícia Figueiredo; Lydiane Hirschler; Radim Jančálek; Vera C Keil; Camille Maumet; Yelda Özsunar; Cyril Pernet; Jan Petr; Joana Pinto; Marion Smits; Esther A H Warnert
Journal:  J Med Biol Eng       Date:  2020-12-03       Impact factor: 2.213

Review 8.  Artificial intelligence in tumor subregion analysis based on medical imaging: A review.

Authors:  Mingquan Lin; Jacob F Wynne; Boran Zhou; Tonghe Wang; Yang Lei; Walter J Curran; Tian Liu; Xiaofeng Yang
Journal:  J Appl Clin Med Phys       Date:  2021-06-24       Impact factor: 2.102

9.  Additional Value of 18F-FDOPA Amino Acid Analog Radiotracer to Irradiation Planning Process of Patients With Glioblastoma Multiforme.

Authors:  David Sipos; Zoltan László; Zoltan Tóth; Peter Kovács; Jozsef Tollár; Akos Gulybán; Ferenc Lakosi; Imre Repa; Arpad Kovács
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.

Authors:  Anahita Fathi Kazerooni; Hamed Akbari; Gaurav Shukla; Chaitra Badve; Jeffrey D Rudie; Chiharu Sako; Saima Rathore; Spyridon Bakas; Sarthak Pati; Ashish Singh; Mark Bergman; Sung Min Ha; Despina Kontos; MacLean Nasrallah; Stephen J Bagley; Robert A Lustig; Donald M O'Rourke; Andrew E Sloan; Jill S Barnholtz-Sloan; Suyash Mohan; Michel Bilello; Christos Davatzikos
Journal:  JCO Clin Cancer Inform       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.